Peer Review History
| Original SubmissionMay 6, 2022 |
|---|
|
PONE-D-22-13314Societal COVID-19 epidemic counter measures and activities associated with SARS-CoV-2 infection in an adult unvaccinated population – a case-control study in Denmark, June 2021PLOS ONE Dear Dr. Ethelberg, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ACADEMIC EDITOR:The reviewers agree that the study is interesting but made many constructive suggestions to improve it.Please address all of these before resubmitting. Please submit your revised manuscript by Aug 01 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Joël Mossong, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information. 3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Partly Reviewer #4: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The study is a case-control study done in Denmark to elucidate factors associated with SARS-CoV-2 infection. Findings from this paper may be context-specific (in the setting of the situation in Denmark, in the setting of the alpha-dominant period, etc.). Still, the study is methodologically sound and provides important insights into controlling SARS-CoV-2. There are several points the authors should address. A couple of other minor points suggested to improve the paper further are also included. 1. The author’s conclusion in the abstract and the main text should be modified so that it is directly supported by the data. Specifically, the following statement is not supported directly by the data: “Transmission of disease through involvement in community activities appeared to occur only rarely, suggesting that community restrictions in place were efficient.” According to Table 2, at least based on the self-reported place of infection, over half of the cases are infected in the community activities. Also, even if the community restrictions in place were efficient, behaviors that are truly high-risk would have been identified as such in the present study design. 2. In the abstract, “confined space” and “contact to known persons” should be separated. “Contact to known persons” should be reworded to “contact to infected individuals.” 3. In the abstract, the sentence “For reference, we provide a timeline of non-pharmaceutical interventions in place in Denmark from February 2020 to March 2022” should be in the earlier part of the abstract to flow better. 4. In the abstract, the citation should not be included and should be removed. 5. If there are any missing data, they should be elaborated on in the tables and provide information on how they were addressed. If not, please ignore this comment. 6. This is a suggestion, but authors should reconsider whether there is a need to do the analysis excluding cases who reported to be infected in their household (Table 4) when the authors are doing an analysis excluding individuals with close contact (Table 5)? I understand that the former data provided some factors that are statistically significant while the latter did not, but it seems arbitrary. 7. The reason to exclude cases who are close contact is partly that cases most likely acquired the virus through this specific contact rather than other community exposures you are asking about in the questionnaire. This can also be mentioned in the manuscript. Reviewer #2: The manuscript "Societal COVID-19 epidemic counter measures and activities associated with SARSCoV-2 infection in an adult unvaccinated population – a case-control study in Denmark, June 2021" is a valuable contribution. Although it does not providing ground-breaking or surprising results, it adds evidence to a steep learning curve from COVID-19 pandemic for epidemiologists, social scientists and policymakers. This contribution is a good example of robust and rapid evidence for policy that can be immediately applied during the crisis and build evidence to better prepare for future pandemics. General suggestions on methods: - Since the outcome of interest is tested positive for SARS-CoV-2, could the authors elaborate on the national criteria for testing that were used during the study period? It is relevant for the international audience, since in every country a "case" could have a slightly different probability of being identified. It is mentioned in the discussion that there was massive testing, possibly including asymptomatic people without any indications, in the occupational setting. In such a case, it is worth introducing this context, and addressing the issue of RT-PCR validity and reliability in the limitation section. - Could the authors explain a bit more why they applied individual matching? With such massive exposures and such common infection, it would be perhaps better to use unmatched design and check for the effect of age and sex on the infection risk? The purpose of the control group is to represent exposures in the source population and matching is a way to prevent confounding. If age and sex are not confounders in a given scenario, matching can actually introduce confounding. I recommend adding to the Methods section a short explanation/rationale to apply individual matching. - Could the authors explain the rationale behind excluding residents previously vaccinated and previously tested positive by RT-PCR? We know now that previous infection or vaccination does not prevent new infections. If one wants to investigate the effect of community exposures on disease risk, maybe it would be a better idea to not exclude infections occuring >6 months previously, for example. Maybe the authors just assumed that with a new disease circulating for a short time, it is safe to assume that all were recently vaccinated and all infected to date were "recently" infected and thus were immune to SARS-CoV-2 infections... These assumptions should be however better explained and addressed in the limitations section. - I recommend using the term matched odds ratios (mOR) instead of odds ratios, to reflect the methodological approach. It should be updated in the entire manuscript, including the abstract. - As mentioned in previous comments, the study has several limitations, not thoroughly revised by the authors. I recommend to be a bit more comprehensive in this matter! Minor corrections: - Abstract line 10: Please move the numbers to the results - Abstract lines 20-21: Do not include citations in the abstract. - Introduction line 39: Why to refer to case-control studies? Do authors refer to studies in Denmark? It would be good to be more precise... - Methods line 70: typo in "ministries" - Results line 163: did the authors mean: "Compared to eligible cases, eligible controls [...]"? - Discussion 279: "conducting" not "conduction" Reviewer #3: This is a case-control study attempting to identify individual and contextual risk factors for SARS-CoV-2 infection in Denmark. The study is well written and has a sound methodology. However, I have a few questions that I believe should be addressed: - In the abstract (line 4) the authors mention they aim at testing the efficiency of such measures - however efficiency requires a resources dimension - do the authors believe they have addressed this? - At the end of introduction (lines 60-61) authors mention the "present an overview of the official restrictions". This seems a bit misleading as the authors actually prepare one as part of their work. I suggest this to be rephrased. - Authors have excluded hospitalized and vaccinated patients. Can they comment on how this might have influenced the results and how this can affect results generalizability? - Data collection: The exposure period ranged from eight to two days before the symptom onset (or test for asymptomatic) for cases. However I could not identify what was the index date for controls - what was the 6-day refer to? Can the authors clarify? - Some of the analysis reported in Table 1 and not described in the methods. I suggest this to be added. - The authors emphasize the alcohol consumption in their results. However this has not been given an in-depth consideration in the discussion. Why the authors believe they have identified this results? Is it really related with the alcohol consumption or it this a proxy for other types of behaviours? - There are negative results in for a series of contexts. Have the authors explored these results in more depth? They raise an hypothesis is the discussion (lines 261 onwards) which has not been corroborated by the sensitivity analysis. Do you see any alternative reasons for these results. Could remote work play a role here? - The authors claim their results support the "efficiency" of existing measures. However I am not entirely convinced here. In fact there is no counterfactual to assess the effectiveness (which I believe is what in fact authors intended to assess) or the impact of those measures. Please comment. Reviewer #4: The authors aim to identify determinants of Sars-COV2 infection in the Denmark in June 2021 using a case –control study. They compare exposure to determinants among 1) 500 cases unvaccinated; 18-49 years old, residents in Denmark, with a RT-PCR test positive result between 8-12 June that were not hospitalized; had not travelled abroad 2) With 529 controls matched on year of birth, sex and municipality with the cases (1 to 1 match). The 6 days (from Day -8 to Day -2 prior to symptom or test +) exposure to determinants was measures by telephone interviews between 15 and 24 June. Conditional logistic regression is correctly use for the analysis. The population from which cases and controls are coming from does not look identical concerning previous infection which is an exclusion criteria for controls but no clear info is provided about the cases. For the community transmission, given the restrictions in place, it means that we could have only controls with a recent negative test but we could have cases with a previous infection or a recent negative test who access public spaces. A subgroup analysis could be performed excluding cases with previous infection and their matched controls, to account for that. In order to understand the results without the need to consult other articles a more detailed description of the questionnaire used is necessary. The conclusion that Contact with another individual with a known infection as the main determinant for SARS-CoV-2 infection is based on sound methodology and nicely reflected in the different sections. Given the strength of the association even adjusting for other determinants will not modify the findings and or conclusions. Sub-group analysis for the community transmission section. The analysis for each determinant is performed separately adjusted for migration back ground, household size and the matching variables. There is no analysis performed by adjusting for all determinants, or for determinants associated with risk of infection in the bivariate analysis. Based on the results from table 4 some of the interpretations about differences between cases and controls are not fully correct. In the results section it states that cases are more likely than controls to have consumed alcohol in a bar. By looking at table 4, the CI95% of the OR for alcohol consumption in a Bar includes the 1 meaning that the difference is not statistically significant. The same logic applies for the indoor sport activities, indoor fitness center and outdoor sport activities. The difference between cases and controls is not statistically significant. The results and discussion sections are to be updated accordingly concerning the community transmission part. (no significant difference for indoor fitness centers, indoor sport activities, alcohol consumption in bars ) It seems that the study is underpowered to detect community determinants of SARS-COV2 infection. Considering a matched 2 controls 1 case design could partially resolve that problem. In the multivariate model, only determinants associated with outcome in the bivariate analysis could be entered. Other Page 4 line 56 (Introduction section) Please rephrase Society was gradually reopening, with now only societal restrictions in place for those individuals who were vaccinated, had recovered from infection or recently tested negative In contradiction with Line 71-72 (methods section) Table 1 Please provide OR for non matching variables. From the bivariate analysis it looks like the migration background and the number of contacts are associated with the risk of becoming a case. In table 2 there is a total of 516 cases reported whereas in the results section only 500 cases are reported as included, please double-check or clarify Table 3 Please provide adjusted OR for migration background and household size as well. General Feedback Please standardize the reporting of OR and CI95% by using everywhere 2 decimals (1,01 instead of 1,0 or 39,00 instead of 39). Inclusive tables with absolute numbers and proportions as well as OR(CI95%) of both bivariate and multivariate analysis would be more easy to read and interpret. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Pawel Stefanoff Reviewer #3: Yes: Andreia Leite Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-13314R1Case-control study of activities associated with SARS-CoV-2 infection in an adult unvaccinated population and overview of societal COVID-19 epidemic counter measures in DenmarkPLOS ONE Dear Dr. Ethelberg, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== All the reviewers agreed that your revision is much improved. Two reviewers still have some minor requests for changes/clarifications. ============================== Please submit your revised manuscript by Nov 05 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Joël Mossong, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: No Reviewer #4: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors addressed most of my comments in a sufficient manner. However, I am still not convinced about the validity of their conclusion, which is critical for this paper. As I mentioned before, even if the community restrictions in place were efficient, behaviors that are truly high-risk would have been identified as such in the present study design. For example, individuals who were positive would be more likely to have history of going to bars and restaurant (resulting in higher odds) if this specific activity is indeed a high-risk behavior in the context of the study population. This should be the case regardless of what type of community restriction is in place. Conversely, as observed in this study, if we do not see any association between a specific behavior and infection, then it would not be possible to conclude that “community restrictions in place were efficient” as authors have done. If history of going to bars and restaurant is really high-risk, then we would see higher ORs. If the policy implemented includes restricting the opening hours at bars and restaurants and if we see that there is a good association between going to bars and restaurants, then we can infer that the policy is appropriately targeting high-risk individuals and high-risk behaviors. Below paper illustrated this exact point: Behavioral factors associated with SARS-CoV-2 infection in Japan. Influenza Other Respir Viruses. 2022;16(5):952-961. Reviewer #2: The authors have carefully considered all comments of reviewers. Therefore, I recommend to accept in the current form. Reviewer #3: Many thanks for fully considering the comments submitted and having provided satisfactory replies. While my comments were fully addressed I have 2 questions from replies from other reviewers: - Authors have mentioned type I errors while refering to issues with power (R#2 and R#4). However I believe they intended to refer to type II erros (failure to reject a null hypothesis when it is false). Please review. - Authors have mentioned in response to R#2 - "During the period around 11,000-26,000 tests were performed per 100,000 population [30]". I suggest to clarify whether these include only PCR or also Rapid Antigen Tests. Reviewer #4: The majority of the comments have been addressed. However there are still few remaining issues to be addressed General Comment : Please consistently report two decimals for OR CI95% throughout the text. In the Results Section / Community determinants of SARS-CoV-2 infection Lines 212-214 Apart from this,controls were more likely to participate in indoor sport activities, mOR: 0.57 (95% CI: 0.32-1.0), and outdoor sport activities, mOR: 0.71 (95% CI: 2130.49-1.0). Comment : Please consistently report two decimals for OR CI95% throughout the text. In the table 4 for in indoor sport activities , mOR: 0.57 (95% CI: 0.32-1.01), and for outdoor sport activities mOR: 0.71 (95% CI: 0.49-1.03) does not support the conclusion that controls were more likely to participate in indoor sport and outdoor sport activities. Discussion : Lines 247-252 The pattern of risk factors seen in the current study was remarkably similar to what we found in our previous study, where also, apart from contact to infected persons with known infections, fitness centers and alcohol consumption in bars and in addition participation in events which involved singing, were identified as being associated with SARS-CoV-2 infection. This second study may therefore be seen as corroborating the findings of the first and it would appear that besides direct contact with infected individuals, under the restrictive measures in place in Denmark, use of fitness centers and social activity involving alcohol constituted actual risk factors. Comment : Use of fitness centers and participation in events which involved singing are not significantly related to the risk of infection in the second study. Please rephrase. Lines 334 -338 We therefore conclude that overall societal restrictions in use in the spring of 2021 were in fact adequate to reducing any potential risk associated with community activities such as participating in cultural events, dining at restaurants, shoppings and public transportation; exceptions being fitness centers and alcohol consumption. which did constitute risks. Comment : Use of fitness center is not significantly related to the risk of infection in the second study. Please rephrase. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Andreia Leite Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Case-control study of activities associated with SARS-CoV-2 infection in an adult unvaccinated population and overview of societal COVID-19 epidemic counter measures in Denmark PONE-D-22-13314R2 Dear Dr. Ethelberg, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Joël Mossong, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-13314R2 Case-control study of activities associated with SARS-CoV-2 infection in an adult unvaccinated population and overview of societal COVID-19 epidemic counter measures in Denmark Dear Dr. Ethelberg: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Joël Mossong Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .